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Abstract
There is increasing recognition of psychiatric co-morbidities in 
individuals with Asperger syndrome (AS) that extend beyond 
the core features of the disorder. Previous research with indi-
viduals with AS and autism are summarized. This study aims 
to examine the behavioural profile of a non-referred AS sample. 
The Childhood Behaviour Checklist (CBCL) was completed 
by parents of fifteen children and adolescents with AS (6–18 
years). Elevated scores across all CBCL scales were found 
relative to the normative group. Social, thought and attention 
problems and anxiety and depressive symptoms were particu-
larly elevated. Research and clinical implications are discussed.
Asperger syndrome (AS) is a pervasive developmental dis-
order on the autism spectrum. It is similar to autistic dis-
order (AD) in that a diagnosis requires two social symptoms 
and one behavioural symptom. However, according to the 
Diagnostic and Statistical Manual-IV (DSM-IV), AS dif-
fers from AD in that there are no marked cognitive delays, 
no clinically significant history of delays in language, cur-
rent communication deficits are not required, and there 
is no upper limit on age of onset (American Psychiatric 
Association [APA], 2000). While individuals with AD with 
average or above average cognitive functioning (referred to 
as high-functioning autism, HFA) also have no marked cog-
nitive delay and may have intact communication abilities, 
the distinction between AS and HFA, according to DSM-IV 
criteria, is based on the history of significant delays in lan-
guage development for HFA, and the age of onset criterion, 
although considerable debate exists about the ability to dif-
ferentiate between the disorders (e.g., Mayes, Calhoun, & 
Crites, 2001; Sciutto & Cantwell, 2005; Tryon, Mayes, Rhodes, 
& Waldo, 2006). There is increasing recognition of psychi-
atric co-morbidities in individuals with autism spectrum 
disorders (ASDs) beyond the core features of the disorders. 
Several mental health problems are thought to be more com-
mon than in the general population, although rates vary 
significantly depending on whether the sample is from the 
community or psychiatric centre, the size of the sample, and 
the disorders under examination. A review of the literature, 
displayed in Table 1, suggests high rates of anxiety disorders, 
depression and attention problems in individuals with an 
ASD, as well as the potential for symptoms of oppositional 
defiant disorder and obsessive compulsive disorder.
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Table 1: Summary of Research on Psychiatric Symptoms in Individuals with ASD
Author Sample N AS
Comparison 
group Measure Psychiatric symptoms
Brereton  
et al., 2006
Clinical 
sample with 
autism; 4–18 
years
381 No Intellectual 
disability 
 DBC-P Attention-Autism > ID
Depression-Autism > ID
Anxiety-Autism > ID
Gadow et al., 
2005
Clinical 
sample with 
PDD;  
6–12 years
284 AS = 80
PDD-
NOS = 118
Clinic 
control, 
community-
based TD 
sample, 
special 
education 
class
CSI-4 Attention – 60%
Depressive symptoms – 6%
Anxiety – 24%
Separation anxiety – 7%
Oppositional – 27%;
Conduct – 7%
Gillott et al., 
2001
Clinical 
sample with 
HFA;  
8–12 years
15 No Specific 
language 
impairment 
and TD
SCAS Anxiety-HFA > SLI
Separation anxiety-HFA > SLI
Obsessive-Compulsive-
HFA > SLI
Hartley  
et al., 2008
Clinical 
sample with 
autism;  
1.5–5.8 years
169 No No CBCL Attention – 39% Clinical range
Anxious/Depressed  
– 4% Clinical range
Withdrawn – 70% Clinical range
Aggression – 23% Clinical range
Holtmann  
et al., 2007
In or out 
patient with 
PDD; 3–20 
years
182 5 No CBCL Attention – mean in Clinical 
range
Anxious/Depressed  
– mean in Borderline range
Social Anxiety – mean  
in Clinical range
Withdrawn – mean  
in Borderline range
Thought – mean in Clinical range
Hurtig et al., 
2009
Clinical 
sample with 
HFA or AS; 
11–17 years
47 AS = 24
HFA = 23
TD sample CBCL
YSR
TRF
Withdrawn-AS/HFA > Control
Social-AS/HFA > Control
Thought-AS/HFA > Control 
(girls)
Attention-AS/HFA > Control 
(girls)
Kim et al., 
2000
Clinical 
sample with 
PDD;  
9–14 years
59 19 No OCHS-R Attention – 17%
Depression – 17%
Anxiety – 14%
Separation anxiety – 9%
Oppositional – 7%
Conduct – 3%
continued on following page
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Table 1: Summary of Research on Psychiatric Symptoms in Individuals with ASD
Author Sample N AS
Comparison 
group Measure Psychiatric symptoms
Kobayashi & 
Murata, 2003
Clinical and 
community 
sample with 
autism; 
young 
adults 
187 No No CBCL Depression – common
Obsessions – common
Leyfer et al., 
2006
Community 
sample with 
autism;  
5–17 years
109 No No ACI Attention – 31%
Depression – 10%
Anxiety – 2%
Phobia – 44%
Separation anxiety – 12%
Social phobia – 8%
Oppositional – 7%
Obsessive-Conduct – 37%
Ming et al., 
2008
Clinical 
sample with 
ASD;  
2–18 years
160 11 No MI Anxiety and depression – 26%
Aggression – 32%
Shtayerman, 
2007
Community 
sample with 
AS; mean 
age = 20 
years 
10 10 No PHQ-A Depression – 20%
Anxiety – 30%
Sukhodolsky 
et al., 2008
Clinical trial 
participants 
with PDD & 
aggression 
& SIB or 
hyper-
activity; 
5–17 years
171 AS = 6; 
PDD-
NOS = 14
No CASI Anxiety – 9%
Phobia – 31%
Separation anxiety – 11%
Social phobia – 20%
Tonge et al., 
1999
Clinical 
sample with 
HFA & AS; 
4–18 years
127 52 No DBC Disruptive-AS > HFA
Antisocial-AS > HFA
Social relating-AS > HFA
Anxiety-AS > HFA
Weisbrot et 
al., 2005 
Clinical 
sample with 
PDD;  
3–12 years
483 AS = 104;
PDD-
NOS = 209
Clinical 
control
ECI-4
CSI-4
Anxiety-PDD > Clinical control
ACI = Autism Co-morbidity Index
AS = Asperger syndrome
CASI = Child and Adolescent Symptom Inventory
CSI-4 = Child Symptom Inventory
DBC = Developmental Behaviour Checklist 
DBC-P = Developmental Behaviour Checklist-Parent
ECI-4 = Early Childhood Inventory-4 
HFA = High functioning autism
ID = Intellectual disability
MI = Medical Interview
OCHS-R = Ontario Child Health Study-Revised
PDD-NOS = Pervasive developmental disorder  
– not otherwise specified
PHQ-A = Patient Health Questionnaire-Adolescent
SCAS = Spence Children’s Anxiety Scale
SLI = Specific language impairment
TD = Typically developing
TRF = Teacher Report Form
YSR = Youth Self Report
(continued)
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There is a paucity of research examining co-
occurring disorders in individuals specifically 
with AS, independent of people with autism 
(cf., Tantum, 2000). Most researchers describe 
their sample as “autism spectrum disorder,” 
combining AS with autism (e.g., Holtmann, 
Bolte, & Poustka, 2007; Ming, Brimacombe, 
Chaaban, Zimmerman-Bier, & Wagner, 2008; 
Sukhodolsky et al., 2008), or excluding those 
with AS altogether. This paper presents data 
of a profile of mental health problems found 
in individuals with AS using the Childhood 
Behaviour Checklist (CBCL; Achenbach & 
Rescorla, 2000), a commonly used measure 
within clinical settings. The pervasiveness of 
co-occurring mental health issues in the ASD 
population highlights the potential utility of 
including a quick and easily administered 
screener to assessments. This study highlights 
to clinicians and researchers the importance of 
understanding the mental health problems that 
occur more frequently in this population.
Although limited, there is some research to 
suggest that those with AS experience more 
psychiatric problems than those with autism. 
For example, Tonge, Brereton, Gray and Einfeld 
(1999) report that 85% of their AS sample met 
criteria for at least one additional disorder, 
relative to 65% of their autism sample. Parents 
of children aged 4–18 years with AS reported 
significantly more disruptive, antisocial, and 
anxious behaviours than those with autism. 
These results are consistent with research that 
demonstrates a negative relationship between 
autism symptoms and psychiatric problems 
in school-age children, with AS reporting 
more anxiety (Weisbrot, Gadow, DeVincent, 
& Pomeroy, 2005) and psychiatric problems 
(Gadow, DeVincent, Pomeroy, & Azizian, 2005) 
than those with a diagnosis either of autism, 
or Pervasive Developmental Disorder-Not 
Otherwise Specified (PDD-NOS).
Other researchers have reported similar degrees 
of depressive and anxious symptoms in children 
with AS and autism (Kim, Szatmari, Bryson, 
Streiner, & Wilson, 2000). Kim and colleagues 
(2000) used the Ontario Child Health Study 
(Boyle et al., 1987), which is based on questions 
from the CBCL, to assess mental health prob-
lems in 59 children (9 –14 years) with either HFA 
or AS and found that, using normative cut-offs, 
between 14–17% of their sample had clinically 
significant levels of anxiety, depression, and 
attention deficit hyperactivity disorder (ADHD), 
and somewhat lower levels for separation anxi-
ety (9%), oppositional behaviour (7%), and con-
duct problems (3%). In addition, they found 
that internalizing problems were more com-
mon than externalizing problems, and noted 
that these disorders had detrimental effects on 
the lives of the parents and children. Contrary 
to their hypotheses, these researchers did not 
find that verbal or non-verbal intelligence and 
specific autism symptoms were significant pre-
dictors of anxiety or depression within their 
sample. They did find that discrepancies scores 
were significant, albeit very limited, predictors 
of mood problems, such that individuals with 
substantially higher verbal than non-verbal 
intelligence reported higher levels of anxiety 
and depression.
Hurtig and colleagues (2009) reviewed results 
from the CBCL completed by parents of 47 ado-
lescents with AS or HFA. Similar to Kim and 
colleagues (2000), no differences were found 
between the AS and the HFA groups; thus the 
groups were combined to create one AS/HFA 
group. They found that 54% of CBCL Total 
Problems scores were in the Borderline range 
(82nd percentile) relative to less than 4% of the 
typically developing (TD) comparison sample. 
Additionally, they found significantly higher 
scores on all Syndrome scales in the AS/HFA 
sample relative to the TD comparison adoles-
cents. In this study, withdrawal, social problems, 
attention and anxiety/depression scores were 
particularly elevated in the AS/HFA sample rel-
ative to the TD comparison group. Gender dif-
ferences within groups were found and no other 
sample characteristics were considered.
These variable results highlight the impor-
tance of further investigation of psychiatric 
symptoms in individuals with AS. The CBCL 
has previously been used to screen for mental 
health problems in individuals with autism. 
Kobayashi and Murata (2003) had 187 parents 
of adults diagnosed with autism complete the 
CBCL, and found elevated depression and 
obsession symptoms. Although the CBCL was 
modified for use with adults by changing the 
wording of some items, the authors point out 
that their results may have underestimated the 
occurrence of psychiatric symptoms given that 
the CBCL is intended for use with children and 
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may have overlooked symptoms more likely to 
affect adults. Holtmann and colleagues (2007) 
used the CBCL with 182 children and adoles-
cents with ASD and analysed the Syndrome 
scales. On average, Social, Attention and 
Thought Problems were in the clinical range, 
and Social Withdrawal, Anxiety/Depression, 
and Total Problems were in the borderline 
range. Hartley and colleagues (2008) used the 
CBCL with 169 young children (1.5–5.8 years) 
with autism. One-third of their sample had 
Total Problems scores in the clinical range, 
with Withdrawal, Attention, and Aggression 
the most frequently endorsed Syndrome scales.
The aim of the current study is to determine 
the frequency and severity of social, emotional, 
and behavioural problems in a well-defined, 
community sample of children and adolescents 
with AS, using the CBCL. The CBCL is a wide-
ly administered screener of psychopathology 
used by many clinicians, and is often a part of 
a test battery of clinicians who work with chil-
dren with AS. Screening is an important and 
easy first step in the detection of mental health 
problems in AS that may be overlooked due to 
diagnostic overshadowing by their AS symp-
toms. At a basic level, the impairments in social 
interaction that characterize the disorder may 
well impact the person’s social-emotional func-
tioning, or vice versa. There are suggestions in 
the research literature, as well as in our clini-
cal experience, of a possible profile of psycho-
pathology common to children with AS, with 
higher rates of internalizing behaviours than 
externalizing behaviours (e.g., anxiety vs. con-
duct disorder), as well as co-occurring attention 
problems, and social and thought problems 
reflective of AS symptoms. Early detection 
can inform early intervention to prevent these 
problems from escalating into psychiatric dis-
orders in adulthood.
Correlation analyses examined the relations 
among CBCL scores and other individual char-
acteristics of the participants, including intel-
ligence, language ability, and severity of ASD 
symptoms. The specific hypotheses of this 
study were:
1) the majority of individuals with AS in this 
study will report at least one subscale within 
the borderline or clinical ranges;
2) as a group, the AS sample will demonstrate 
overall higher rates of all symptoms relative 
to the normative sample;
3) Anxious/depressed, Attention, Social, and 
Thought Problem syndrome scales will be 
particularly elevated within the AS sample;
4) Affective, Anxiety, and Attention Deficit/
Hyperactivity DSM scales will be notably 
high within the AS sample;
5) Internalizing aggregate scores will be great-
er than Externalizing score; and
6) correlations between sample characteristics 
and CBCL scores will be non-significant.
Methods
Participants
Fifteen children with AS between the ages of 
6–18 years participated in this study. Inclusion 
criteria included no history of developmental 
language delay and average or above average 
cognitive and current language functioning. 
Children were recruited through the Autism 
Spectrum Disorders-Canadian American 
Research Consortium registry and from agen-
cies that serve families of individuals with 
AS. Participants had a primary diagnosis of 
AS, which was confirmed through a review of 
psychological reports using DSM-IV criteria 
and by scores on the Krug Asperger’s Disorder 
Index (KADI; Krug & Arick, 2003). KADI stan-
dard scores ranged from 74–114, comparable to 
the normative sample of individuals with AS 
(M = 100.27, SD = 10.47). ADI-R scores were not 
used for confirmation of diagnosis because, as 
noted by Autism Genetic Resource Exchange 
(AGRE, n.d.), there is no validated algorithm 
for identifying AS on the ADI-R. Scores for 
our group varied accordingly: 56% of the AS 
group scored in the autism range, 11% in the 
Not Quite Autism range, and 33% in the Broad 
Spectrum range.
Table 2 displays sample characteristics includ-
ing age, IQ, language skill, and autism and AS 
symptom severity.
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Measures
The Childhood Behavior Checklist (CBCL; 
Achenbach & Rescorla, 2000) was used to assess 
behavioural, emotional, and social problems. 
It is a parent-report measure appropriate for 
use with children aged 6–18 years with strong 
empirically supported rating scales for assess-
ing overall psychopathology, and with several 
syndrome subscales, developed using princi-
pal components analysis. It is a 113-item ques-
tionnaire that takes 15–20 minutes to complete. 
Parents are asked to rate their child within 
the past 6 months using a three-point scale 
(0 = not true, 1 = somewhat or sometimes true, 
and 2 = very true or often true). Scores for 
Internalizing, Externalizing and Total Problems 
are provided, along with several subscale scores. 
Internalizing behaviours occur within the self 
and represent an over-controlled or inhibited 
pattern of behaviors. The Internalizing score 
comprises the following syndrome scales: 
Anxious/depressed, Withdrawn/depressed, 
and Somatic Complaints. Externalizing behav-
iours tend to be directed outward, external to 
the individual. The Externalizing score compris-
es the Rule-breaking and Aggressive Behavior 
Syndrome scales. Additional Syndrome scales 
are Attention, Social, and Thought Problems. 
The DSM scales are: Affective, Anxiety, Somatic, 
Attention Deficit/Hyperactivity, Oppositional 
Defiant, and Conduct Problems. T-scores are 
provided, with higher scores reflecting more 
problematic behaviour. A T-score of 50 repre-
sents the mean of the normative group with 
the standard deviation of 10. On syndrome and 
DSM scales scores, T-scores of 65–69 represent 
the borderline range (93rd to 97th percentile), and 
T-scores above 70 fall into the clinical range 
(above the 97th percentile). For aggregate and 
Total Problems scores, the borderline range is 
defined by T-scores in the 60–63 range (84th to 
90th percentile) and T-scores above 63 are in the 
clinical range. Extensive reliability and validity 
Table 2: Sample Characteristics
N Mean SD Range
Age 15 12.07 2.86  6–16
FSIQ 15 115.40 15.19  89–141
VIQ 15 116.47 16.61  88–150
PIQ 15 111.47 13.99  86–133
VIQ-PIQ 15 5.27 14.66  -18–36
PPVT-III 15 113.73 21.19  80–143
EOWPVT-2000 15 114.13 12.09  95–141
KADI 15 100.67 9.57  74–114
ADI-R 
Social
10 17.20 6.44  6–24
ADI-R 
Communication
10 12.70 6.73  5–21
ADI-R 
Repetitive & Restricted Behaviour
10 6.00 2.63  3–11
ADI-R 
Developmental History
10 2.50 1.35  0–4
FSIQ = Full-scale Intelligence Quotient; VIQ = Verbal Intelligence Quotient; PIQ = Performance Intelligence Quotient; 
VIQ – PIQ = Verbal Intelligence Quotient minus Performance Intelligence Quotient; PPVT-III = Peabody Picture Vocabulary 
Test-3rd Edition; EOWPVT-2000 = Expressive One-Word Picture Vocabulary Test-2000 Edition; KADI = Krug Asperger’s 
Disorder Index; ADI-R = Autism Diagnostic Interview-Revised
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data are reported in the manual (Achenbach, 
1991) and reviews indicate strong overall psy-
chometric properties (Flanagan & Watson, 2005).
Cognitive and language functioning
The Wechsler Abbreviated Scale of Intelligence 
(WASI; The Psychological Corporation, 1999) 
was used as a brief estimate of intellectual 
skills, and yielded a Verbal IQ, Performance IQ, 
and Full Scale IQ score. The WASI was selected 
because the administration time is approxi-
mately 30 minutes and it is rated as having 
very strong psychometric properties overall, 
its Full Scale IQ score correlating .81 and .87, 
respectively, with the full scale IQ scores of the 
two measures from which it was derived, the 
Wechsler Intelligence Scale for Children-III and 
the Wechsler Adult Intelligence Scale-III, and 
with similar correlations for the subscales (e.g., 
Keith, Lindskog, & Smith, 2001; Sattler, 2001; 
The Psychological Corporation, 1999).
The Peabody Picture Vocabulary Test-III (PPVT-III; 
Dunn & Dunn, 1997) was used as a screening 
test of single-word listening comprehension.
The Expressive One-Word Picture Vocabulary 
Test-2000 Edition (EOWPVT-2000; Brownell, 
2000) was used as a measure of expressive one-
word vocabulary.
ASD measures
Autism Diagnostic Interview – Revised (ADI-R; 
Lord, Rutter, & LeCouteur, 1994) is a standard-
ized, semi-structured clinical review for care-
givers of children and adults. It was admin-
istered to parents to identify the severity of 
symptoms reported for participants using the 
AGRE affective status categories.
The Krug Asperger’s Disorder Index (KADI; Krug 
& Arick, 2003) is a parent-report scale that indi-
cates the presence or absence of behaviours 
that are indicative of AS. It is used to identify 
those with AS and to discriminate between AS 
and high functioning autism. It was used to aid 
in the confirmation of AS diagnosis. In a review 
of five diagnostic tools for AS (Campbell, 2005), 
the KADI had the strongest psychometric 
properties.
General Procedure
This study was reviewed and approved by the 
Office of Research Ethics at York University. The 
data reported in the paper were obtained as part 
of a larger experimental procedure. Participants 
completed two experimental tasks that involved 
presentation of auditory and visual stimuli on a 
large screen, which required 14 minutes to com-
plete, and are not reported here. After a brief 
break, children were assessed using the WASI, 
the PPVT-III, and the EOWPVT-2000, lasting 
approximately 1.0–1.5 hours in total. During 
the experiment, parents were asked to complete 
the CBCL, the KADI, and an optional measure 
of ASD symptoms that was in the process of 
becoming standardized.
Analyses
A series of one-sample t-tests were calculated to 
compare the AS group’s mean CBCL syndrome 
scores to a T-score of 50, indicative of the mean 
for the typically developing normative group. 
Due to the large number of comparisons, alpha 
was set to .01. Descriptive analyses were also 
conducted to determine what percentage of 
participants fell into the borderline and clinical 
ranges. A paired-sample t-test was conducted 
to determine differences between internalizing 
and externalizing behaviour within the sample. 
Post hoc contrasts were used to determine dif-
ference among symptom scales. Correlational 
analyses were conducted to determine the rela-
tions among age, language ability (PPVT-III 
and EOWPVT-2000 scores), intelligence (WASI 
FSIQ, VIQ, and PIQ scores and VIQ/PIQ split), 
symptom severity (KADI and ADI-R scores), 
and CBCL Internalizing, Externalizing, and 
Total scores.
Results
As shown in Table 3, all symptom scores were 
significantly greater than the normative sam-
ple mean. Overall, the Anxiety/depression, 
Social Problems, Thought Problems, Attention 
Problems Syndrome scales, and the Anxiety, 
DSM-IV scale, were found to have a mean in 
the borderline range. In addition, the mean 
Internalizing and Total problems scores were 
found to be in the clinical range. Significance 
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levels were such that even conservative correc-
tions for the multiple t-tests still indicated sig-
nificant differences.
All participants had at least one score in the 
borderline range, and eighty percent of par-
ticipants had at least one symptom score in 
the clinical range. Sixty-seven percent of par-
ticipants showed a Total Problems score in the 
clinical range. The scales most commonly in 
the borderline or clinical range in this sam-
ple were: Thought Problems (80%), Anxiety 
Problems (67%), Anxious/Depressed (67%), 
Attention Problems (63%), and Social Problems 
(60%; see the first column of Table 3). Figure 1 
demonstrates the group’s AS symptom profile, 
through boxplot analyses. The degree of vari-
ability and presence of outliers should be con-
sidered when interpreting the results.
The paired-sample t-test revealed a trend 
towards a difference between internalizing 
behaviour and externalizing behaviour scores, 
t(14) = 2.39, p = .03 (significant at the alpha = .05 
level, but not at the adjusted alpha of .01), with 
the AS group showing significantly higher 
levels of internalizing problems. Post hoc con-
trasts with Sidak-Bonferroni adjustment con-
firmed that there were significant differences 
among the symptom scales, with greater sever-
Table 3: Mean T-scores of AS Participants on CBCL Syndrome and DSM-IV Scales
Scale
%  
Clinical
Mean  
(SD) t(df) p-value Cohen’s d
Syndrome scales
Anxious/depressed  20 (47)  66.13 (8.54)  7.31 (14)  < .001 1.73
Withdrawn/depressed  13 (20)  62.40 (10.68)  4.49 (14)  .001 1.19
Somatic complaints  6 (13)  59.60 (6.81)  5.46 (14)  < .001 1.12
Social problems  40 (20)  65.87 (8.35)  7.36 (14)  < .001 1.72
Thought problems  47 (33)  68.87 (7.53)  9.70 (14)  < .001 2.13
Attention problems  30 (33)  66.73 (7.98)  8.12 (14)  < .001 1.85
Rule-breaking behaviour  13 (0)  56.33 (7.29)  3.36 (14)  .005 0.72
Aggressive behaviour  13 (30)  61.93 (10.69)  4.33 (14)  .001 1.15
DSM scales
Affective problems  13 (33)  64.87 (10.95)  5.26 (14)  < .001 1.42
Anxiety problems  20 (47)  66.33 (7.74)  8.17 (14)  < .001 1.83
Somatic problems  20 (0)  57.13 (6.48)  4.26 (14) .001 0.85
ADHD problems  40 (20)  64.80 (7.27)  7.88 (14)  < .001 1.69
ODD problems  27 (13)  61.07 (8.15)  5.26 (14)  < .001 1.21
Conduct problems  13 (13)  59.00 (10.17)  3.43 (14) .004 0.89
Aggregate scores
Internalizing  53 (13)  65.33 (7.42)  8.00 (14)  < .001 1.74
Externalizing  20 (33)  58.47 (10.11)  3.24 (14)  .006 0.84
Total problems  67 (13)  65.73 (7.24)  8.42 (14)  < .001 1.80
ADHD = attention deficit hyperactivity disorder; ODD = oppositional defiant disorder
Note: scores of 65–69 are in the Borderline range, indicating elevated risk for that variable; scores > 70 are considered as likely in 
the Clinical range. For the aggregate scores, scores of 60–63 are in the Borderline Range, and scores ≥ 64 are in the Clinical range. 
A Cohen’s d of 0.2 is considered a “small” effect size, 0.5 is “medium,” and > 0.8 is considered a “large” effect size.
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ity of Thought symptoms and Attention symp-
toms relative to the severity of Rule-breaking 
symptoms, ΔM = 12.3, p = .001 and ΔM = 10.4, 
p = .003, respectively. No other significant dif-
ferences based on symptom severity on the 
CBCL emerged.
Correlational analyses indicated no significant 
correlations among any of the demographic 
variables (age, language ability, intelligence, 
age, autism symptom severity) and the CBCL 
Internalizing, Externalizing or Total Problems 
scales (all p ≥ .14).
Discussion
These results indicate that on average, parents 
of individuals with AS reported significantly 
higher symptom severity on every scale of the 
CBCL relative to the norming population, thus 
supporting the first and second hypotheses. 
Sixty-seven percent of participants showed 
a total problems score in the clinical range, 
and all participants had at least one scale that 
fell one and a half standard deviation points 
above the population average. This is consis-
tent with Tonge and colleagues (1999), who 
reported that 85% of their AS sample met cri-
teria for at least one disorder. As predicted in 
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Figure 1. Boxplots of syndrome and DSM-IV scales
Note: vertical line = range; box = middle 50% of scores; line in box = median; * = major outliers;  = minor outliers
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the third and fourth hypotheses, the scales that 
were most commonly endorsed in the sample 
were Thought, Anxiety, Social, Affective, and 
Attention Problems. These results are consistent 
with the current literature on AS and anxiety, 
depression, and obsessions (Gadow et al., 2005; 
Hartley et al., 2008; Hurtig et al., 2009; Kim et 
al., 2000; Kobayashi & Murata, 2003; Tonge et 
al., 1999; Weisbrot et al., 2005). Consistent with 
our fifth hypothesis, the results indicate that 
using the CBCL, internalizing behaviour is sig-
nificantly more problematic than externalizing 
behaviour. Individuals with AS also appear at 
significant risk for associated thought prob-
lems, anxiety and depression, social problems, 
and attention problems, and it is important to 
further investigate these linkages. The sixth 
hypothesis regarding correlations between 
sample characteristics and CBCL scores was 
also supported. Consistent with Kim and col-
leagues (2000), intelligence, language ability, 
and autism symptoms were not significantly 
correlated with CBCL scores. This is not sur-
prising given the homogeneity of these scores 
within the sample and the small sample size.
Our AS sample’s CBCL profile is consistent with 
the profile found in the Pervasive Developmental 
Disorder (PDD) group examined by Holtmann 
and colleagues (2007), with a few notable and 
predictable exceptions. Across scales, the means 
for our AS sample were somewhat lower than 
for the Holtmann et al. PDD group. This may 
suggest that the AS group showed less psycho-
pathology than the PDD group in their study, 
although theirs was a mixed sample. It is more 
likely that the means from our sample underes-
timate the actual symptom severity of the sam-
ple. The frequency of reported symptoms that 
fell into the borderline and clinical ranges in our 
sample was quite high, and the group means 
were reduced by the small number of scores in 
the non-clinical range.
The symptoms that emerged as being particu-
larly problematic in both the Holtmann and 
colleagues’ (2007) PDD sample, and the Hurtig 
et al. (2009) AS plus HFA sample included 
withdrawal, social problems, attention, and 
anxiety/depression. Hartley and colleagues 
(2008) also found withdrawal to be particularly 
problematic in their sample of young children 
with autism. These differences are quite consis-
tent with our findings, except for withdrawal, 
which comprises both withdrawal from activi-
ties and from other people. Withdrawal charac-
terizes autism more severely, and each of those 
studies used mixed diagnostic samples, com-
pared to our sample, which was limited to AS. 
In AS, unsuccessful attempts at social approach 
are more common than withdrawal.
Hurtig and colleagues (2009) were unique in not 
finding thought problems to be as problematic in 
their sample; however, they removed three items 
from the thought problems subscale due to over-
lap with autism symptomatology. The Hartley 
and colleagues (2008) study was also unique in 
that aggression was frequently endorsed relative 
to other scales. This may be related to the age 
of their sample (1.5–5.8 years); it is possible that 
aggression is more frequently noted in younger 
children with autism than older children with 
autism, or individuals with AS.
Thought problems (including obsessive thoughts 
and repetitive actions) and social problems as 
measured by the CBCL may overlap with sev-
eral of the central diagnostic features of AS, 
including repetitive and restricted behaviours 
and social difficulties (Hurtig et al., 2009). Future 
research is needed to determine if these prob-
lems may be indicative of co-occurring OCD 
or psychotic symptoms, or simply part of the 
expression of ASD. More distinct from ASD 
symptoms, however, are attention problems, 
anxiety, and depression, which are not consid-
ered core features of AS, and elevated scores in 
these domains are likely more indicative of co-
morbidity. Attention problems frequently occur 
in individuals with ASD, although these features 
are not considered core to the disorder. While 
the DSM-IV prohibits the diagnosis of ADHD 
in individuals with PDD, due to overlap in diag-
nostic features, some clinicians will diagnose 
ADHD in individuals with PDD. A more criti-
cal question that could be addressed in future 
research is at what point should the core charac-
teristics of AS perhaps be expanded to recognize 
that the majority of individuals with ASD expe-
rience these issues. Additional research might 
also include information from multiple sources, 
such as teachers, as parents may tend to under-
report psychiatric symptoms in their children, 
and an additional rating source would help pro-
vide additional confidence in interpretation of 
reported symptoms. If it is the case that parents 
were under-reporting, then the present results 
may actually be an underestimation of existing 
problems in the population.
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While the small sample size, reliance on parent 
report only and lack of an autism or typically 
developing comparison groups may be limiting 
factors for the present study, this research high-
lights the importance of considering co-mor-
bidity when assessing the AS population. For 
that reason, a broad social, behavioural, and 
emotional problem screen, such as the CBCL, 
should be included in any assessment battery. 
This study also underscores the importance of 
determining the efficacy of current or modified 
treatments for mental health problems in indi-
viduals with AS. Finally, additional research 
is warranted to determine if there are specific 
early symptoms of AS that predict later behav-
iour problems in this population, and that cli-
nicians can use as indicators of risk that may 
require early intervention.
Key Messages from This Article
People with disabilities: It is important to talk 
to your health care provider if you are feeling 
anxious, depressed, or have other mental health 
concerns. This will help them to make sure that 
you are provided with the best possible care.
Professionals: It is important to screen for 
additional mental health issues, including 
anxiety, depression, and attention difficulties, 
when working with individuals with autism 
Spectrum Disorders as these are not core fea-
tures and should be evaluated separately.
Policy makers: Policy to promote mental health 
screening and interventions for individuals 
with autism spectrum disorders is necessary to 
ensure that their often complex mental health 
needs are met.
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